EUVIMEDEUVIMED entdecken
Crossref

Effects of Neoadjuvant Fluorouracyl-Adriamycin- Cytoxan (FAC) Chemotherapy Response to CD4 + Serum Levels In Breast Cancer

Ade Permana, Benny Kusuma, Nur Qodir, Legiran

Sriwijaya Journal of Surgery · 2018

DOI: 10.37275/sjs.v1i1.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sriwijaya Journal of Surgery, 2018. Verfasst von Ade Permana und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

CD4+ T-helper has an important role in immune system modulation especially to maintain long-term anti tumor effect. CD4+ also serves to activate CD8+ for destroyed the tumor cells. It was expected there were role of immunity on tumor growth and response of breast cancer chemotherapy to CD4+ levels serum. Furthermore, this study was aimed to investigate the effects of neoadjuvant chemotherapy on CD4+ levels in patients with locally advanced breast cancer at General Hospital Dr. Mohammad Hoesin Palembang.

Method

This study was a non-comparable clinical trial by looking at serum CD4+ levels in patients with locally advanced breast cancer before and after neoadjuvant chemotherapy.

Results

Of the 30 subjects the subject age ranged from 33-66 years with an average of 45 years. There were 17 patients with contraception history (56.7%), 13 patients with family history of breast cancer (43.3%). From this study, it was obtained 23 patients with good chemotherapy response (76.7%) and there were 7 patients who had poor chemotherapy response after neoadjuvan chemotherapy (23.3%). Paired t-test analysis showed that there was a significant difference in mean CD4+ count before and after neoadjuvan chemotherapy. At the CD4+ level before chemotherapy 775.55 had a sensitivity of 60% and a specificity of 57% (cut of point). While CD4+ levels after chemotherapy 470.85 with sensitivity of 60% and specificity of 57%.

Conclusion

CD4+ pre-chemotherapy examination had a sensitivity score of 60% and a specificity of 57% in predicting neoadjuvant chemotherapy response.

Zitieren

APA

Permana, A., Kusuma, B., Qodir, N., & Legiran (2018). Effects of Neoadjuvant Fluorouracyl-Adriamycin- Cytoxan (FAC) Chemotherapy Response to CD4 + Serum Levels In Breast Cancer. Sriwijaya Journal of Surgery. https://doi.org/10.37275/sjs.v1i1.1

Vancouver

Permana A, Kusuma B, Qodir N, Legiran. Effects of Neoadjuvant Fluorouracyl-Adriamycin- Cytoxan (FAC) Chemotherapy Response to CD4 + Serum Levels In Breast Cancer. Sriwijaya Journal of Surgery. 2018. doi:10.37275/sjs.v1i1.1

BibTeX
@article{Permana2018,
  author = {Permana, Ade and Kusuma, Benny and Qodir, Nur and Legiran},
  title = {Effects of Neoadjuvant Fluorouracyl-Adriamycin- Cytoxan (FAC) Chemotherapy Response to CD4 + Serum Levels In Breast Cancer},
  journal = {Sriwijaya Journal of Surgery},
  year = {2018},
  doi = {10.37275/sjs.v1i1.1}
}
Kostenlos starten →